Third-Party Tested by Verum Analytics
BPC-157 & TB-500
Research blend combining BPC-157 and TB-500 peptides for comparative studies.
Third-Party Tested by Verum Analytics
Albert's Verdict
This is the blend I'd reach for first in any wound-model research design. BPC-157 handles the vascular and inflammatory signaling while TB-500 drives cellular migration and reorganization — they operate on complementary mechanisms without redundancy.
View COA✓ In stock - Ships same day
Arrives as lyophilized (powder) form
Shipped freeze-dried for maximum stability and shelf life. See laboratory preparation guide for handling instructions.
Product Description
BPC-157 & TB-500 Blend combines two of the most extensively researched wound-model research peptides into a single formulation. BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4 Fragment) work through complementary mechanisms—BPC-157 primarily through nitric oxide and growth factor modulation, and TB-500 through actin sequestration and cell migration.
Blend Composition:
- 5/5 mg variant: 5 mg BPC-157 + 5 mg TB-500
- 10/10 mg variant: 10 mg BPC-157 + 10 mg TB-500
Research Applications:
- comparative actin-pathway and wound-model studies
- Combined angiogenic and anti-inflammatory models
- Musculoskeletal research research
- Comparative efficacy vs. individual peptide administration
- Dose-response optimization for combination protocols
Quality Standards:
- Each component: ≥99% purity verified by HPLC
- Third-party tested with COA included
- Pre-blended for research convenience
FOR RESEARCH USE ONLY. Not for human consumption.
Technical Specifications
- Molecular Formula
- C62H98N16O22 + C212H350N56O78S
- Molecular Weight
- 1419.53 + 4963.5 g/mol
Frequently Researched Together
Commonly studied alongside in laboratory settings
Learn More About This Peptide
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.